Difficulty: Medium
Average Score: 77%
Practice
The first-line therapy for mild-persistent asthma is:
Correct answer
C
Rationale
Mild-persistent asthma symptoms more than twice weekly needs daily control with low-dose inhaled corticosteroids to reduce airway inflammation, per NHLBI guidelines. Montelukast is adjunctive, theophylline outdated, and long-acting agonists pair with steroids in higher steps. This cornerstone therapy prevents exacerbations, aligning with evidence favoring early anti-inflammatory intervention over bronchodilation alone for sustained control.